Vitamin D3 might improve headache characteristics and protect against inflammation in migraine: a randomized clinical trial

被引:0
作者
Zeinab Ghorbani
Mansoureh Togha
Pegah Rafiee
Zeynab Sadat Ahmadi
Reyhaneh Rasekh Magham
Mahmoud Djalali
Sahar Shahemi
Fahimeh Martami
Mahnaz Zareei
Soodeh Razeghi Jahromi
Shadi Ariyanfar
Maryam Mahmoudi
机构
[1] Tehran University of Medical Sciences,Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics
[2] Tehran University of Medical Sciences,Headache Department, Iranian Center of Neurological Research, Neuroscience Institute
[3] Tehran University of Medical Sciences,Headache Department, Neurology Ward, Sina University Hospital, School of Medicine
[4] Shahid Beheshti University of Medical Sciences,Student Research Committee, (Department and Faculty of Nutrition Sciences and Food Technology)
[5] Iran University of Medical Sciences,Department of Nutrition, School of Health
[6] Science & Research Branch,Department of Nutrition, Faculty of Medical Sciences
[7] Islamic Azad University,Nutrition and Endocrine Research Center, Research Institute for Endocrine Sciences
[8] Shahid Beheshti University of Medical Sciences,Department of Clinical Nutrition and Dietetics, Faculty of Nutrition and Food Technology
[9] Shahid Beheshti University of Medical Sciences,Pediatric Gastroenterology and Hepatology Research Center, Children’s Medical Center
[10] Tehran University of Medical Sciences,Dietitians and Nutrition Experts Team (DiNET)
[11] Universal Scientific Education and Research Network (USERN)Tehran,undefined
来源
Neurological Sciences | 2020年 / 41卷
关键词
Analgesics; Cholecalciferol; Frequency; Headache attacks; Inflammation; Severity;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1183 / 1192
页数:9
相关论文
共 224 条
[1]  
Steiner TJ(2018)Migraine is first cause of disability in under 50s: will health politicians now take notice? J Headache Pain 19 17-210
[2]  
Stovner LJ(2007)The global burden of headache: a documentation of headache prevalence and disability worldwide Cephalalgia 27 193-87
[3]  
Vos T(2017)Sex differences in the epidemiology, clinical features, and pathophysiology of migraine Lancet Neurol 16 76-16
[4]  
Jensen R(2018)A phase-by-phase review of migraine pathophysiology Headache 58 4-S15
[5]  
Katsarava Z(2005)Migraine as an inflammatory disorder Neurology 64 S9-311
[6]  
Stovner L(2005)Neurogenic inflammation and migraine: implications for the therapeutics Mol Interv 5 304-248
[7]  
Hagen K(2007)An overview on immune system and migraine Eur Rev Med Pharmacol Sci 11 245-314
[8]  
Jensen R(2018)Neurogenic inflammation and its role in migraine Semin Immunopathol 40 301-525
[9]  
Katsarava Z(2016)Serum levels of pentraxin-3 and other inflammatory biomarkers in migraine: association with migraine characteristics Cephalalgia 36 518-1897
[10]  
Lipton R(2012)Structural brain changes in migraine Jama 308 1889-80